N/A
N=39
Evaluation of a New mHealth Tympanometer
Hearing Loss
Bottom Line
View on ClinicalTrials.gov: NCT05666505 ↗Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Classification Agreement Between Prototype mHealth Tympanometer and Commercial Tympanometer — 93.33 Percent Agreement
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Prototype mHealth tympanometer (Device); Standard of care commercial tympanometer (Device)
- Age
- Pediatric, Adult, Older Adult · 1+ yrs
- Sex
- All
- Sponsor
- University of Arkansas
- Primary completion
- Dec 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Classification Agreement Between Prototype mHealth Tympanometer and Commercial Tympanometer |
93.33 | — |
| PRIMARY Classification Agreement Between Audiologist and ML Algorithm Interpretations Using Prototype mHealth Tympanometer |
0.81 | — |
Summary
Children in rural and underserved communities experience a disproportionately high burden of infection-related hearing loss, which is often preventable with timely identification and follow-up care. A tympanometer is a device that evaluates the health of the middle ear but is often not used in screening programs due to barriers of high cost and need for trained professionals such as audiologists to use the device. To address these barriers, a low cost, lay friendly, mobile health (mHealth) prototype tympanometer has been developed. In addition, a machine learning (ML) algorithm has been designed to guide lay users to interpret tympanometer results, overcoming the need for audiologists. Broad implementation of the lay friendly tympanometer and ML algorithm will transform screening in areas where prevalence of infection-related hearing loss is high, and access to specialty care is limited.
In this study the prototype mHealth tympanometer will be evaluated against commercial tympanometry. It will be used by audiologists, an essential step before testing the performance of the device with lay users. Approximately 20 adult patients and 10 pediatric patients with various middle ear pathologies will be enrolled in the study, with the goal of obtaining 60 ears with data from both the prototype and commercial tympanometers. Audiologists will obtain tympanometry measurements on both ears of each participant and interpret the results, first with the prototype device and then with the commercial tympanometer that is typically used during a clinical evaluation. Tympanometry interpretation will include classification into one of 3 categories (Type A, B, or C). Agreement in results between the prototype and commercial devices will be assessed. Agreement between audiologist interpretations and the ML algorithm from the prototype mHealth tympanometer will be assessed.
Eligibility Criteria
Inclusion Criteria
- Presenting to Audiology Clinic for evaluation, where tympanometry is warranted for testing at the discretion of the audiologist
- Presence of various middle ear health states/pathologies that result in Type A, B, C tympanograms
- English-speaking
Exclusion Criteria
- Children or adults with cognitive disabilities
- Unable to provide consent/assent
- Individuals who are unable to sit still
- Any other condition that in the opinion of the investigator, might interfere with the safe conduct of the study or place the participant at increased risk
Data sourced from ClinicalTrials.gov (NCT05666505). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.